Personal information

Websites & social links

LinkedIn
Google Scholar
Gutkind Lab
Allison Lab

Other IDs

Scopus Author ID: 57195436937

Keywords

Immunology, Cancer, Immunotherapy

Countries

United States

Activities

Collapse all

Employment (2)

University of Texas MD Anderson Cancer Center: Houston, TX, US

2015-04-13 to 2019-08 | Senior Research Assistant (Immunology)
Employment
Source: Self-asserted source
Nana-Ama A. S. Anang

Bowie Junior High School: Odessa, TX, Texas, US

2014-10-01 to 2015-03-18 | Senior AVID Tutor
Employment
Source: Self-asserted source
Nana-Ama A. S. Anang

Education and qualifications (2)

University of California San Diego: La Jolla, CA, US

2019-09 to present | Ph.D. (Biomedical Sciences)
Education
Source: Self-asserted source
Nana-Ama A. S. Anang

University of Texas at Austin: Austin, TX, US

2011-01-01 to 2014-08-31 | BSc in Biology (Marine and freshwater Biology )
Education
Source: Self-asserted source
Nana-Ama A. S. Anang

Professional activities (1)

American Society for Pharmacology and Experimental Therapeutics: Rockville, MD, US

2020 to present | Member
Service
Source: Self-asserted source
Nana-Ama A. S. Anang

Works (11)

Anti-CTLA-4 generates greater memory response than anti-PD-1 via TCF-1

Proceedings of the National Academy of Sciences
2025-01-14 | Journal article
DOI: 10.1073/pnas.2418985122
Contributors: Stephen Mok; Huey Liu; Didem Ağaç Çobanoğlu; Nana-Ama A. S. Anang; James J. Mancuso; E. John Wherry; James P. Allison
Source: check_circle
Crossref

Data from A Genetic Mouse Model Recapitulates Immune Checkpoint Inhibitor–Associated Myocarditis and Supports a Mechanism-Based Therapeutic Intervention

2023-04-03 | Preprint
DOI: 10.1158/2159-8290.c.6547996
Contributors: Spencer C. Wei; Wouter C. Meijers; Margaret L. Axelrod; Nana-Ama A.S. Anang; Elles M. Screever; Elizabeth C. Wescott; Douglas B. Johnson; Elizabeth Whitley; Lorenz Lehmann; Pierre-Yves Courand et al.
Source: check_circle
Crossref

Data from A Genetic Mouse Model Recapitulates Immune Checkpoint Inhibitor–Associated Myocarditis and Supports a Mechanism-Based Therapeutic Intervention

2023-04-03 | Preprint
DOI: 10.1158/2159-8290.c.6547996.v1
Contributors: Spencer C. Wei; Wouter C. Meijers; Margaret L. Axelrod; Nana-Ama A.S. Anang; Elles M. Screever; Elizabeth C. Wescott; Douglas B. Johnson; Elizabeth Whitley; Lorenz Lehmann; Pierre-Yves Courand et al.
Source: check_circle
Crossref

Supplementary Data from A Genetic Mouse Model Recapitulates Immune Checkpoint Inhibitor–Associated Myocarditis and Supports a Mechanism-Based Therapeutic Intervention

2023-04-03 | Preprint
DOI: 10.1158/2159-8290.22535971.v1
Contributors: Spencer C. Wei; Wouter C. Meijers; Margaret L. Axelrod; Nana-Ama A.S. Anang; Elles M. Screever; Elizabeth C. Wescott; Douglas B. Johnson; Elizabeth Whitley; Lorenz Lehmann; Pierre-Yves Courand et al.
Source: check_circle
Crossref

Supplementary Data from A Genetic Mouse Model Recapitulates Immune Checkpoint Inhibitor–Associated Myocarditis and Supports a Mechanism-Based Therapeutic Intervention

2023-04-03 | Preprint
DOI: 10.1158/2159-8290.22535971
Contributors: Spencer C. Wei; Wouter C. Meijers; Margaret L. Axelrod; Nana-Ama A.S. Anang; Elles M. Screever; Elizabeth C. Wescott; Douglas B. Johnson; Elizabeth Whitley; Lorenz Lehmann; Pierre-Yves Courand et al.
Source: check_circle
Crossref

Lymphatic-preserving treatment sequencing with immune checkpoint inhibition unleashes cDC1-dependent antitumor immunity in HNSCC

Nature Communications
2022-07-25 | Journal article
DOI: 10.1038/s41467-022-31941-w
Contributors: Robert Saddawi-Konefka; Aoife O’Farrell; Farhoud Faraji; Lauren Clubb; Michael M. Allevato; Shawn M. Jensen; Bryan S. Yung; Zhiyong Wang; Victoria H. Wu; Nana-Ama Anang et al.
Source: check_circle
Crossref

Lymphatic-Preserving Treatment Sequencing with Immune Checkpoint Inhibition Unleashes cDC1-Dependent Antitumor Immunity in HNSCC

2022-02-03 | Preprint
DOI: 10.1101/2022.02.01.478744
Contributors: Robert Saddawi-Konefka; Aoife O’Farrell; Farhoud Faraji; Lauren Clubb; Michael M. Allevato; Nana-Ama A. S. Anang; Shawn M. Jensen; Zhiyong Wang; Victoria H. Wu; Bryan S. Yung et al.
Source: check_circle
Crossref

A Genetic Mouse Model Recapitulates Immune Checkpoint Inhibitor-Associated Myocarditis and Supports a Mechanism-Based Therapeutic Intervention.

Cancer discovery
2021-03-02 | Journal article
DOI: 10.1158/2159-8290.cd-20-0856
PMID: 33257470
Source: Self-asserted source
Nana-Ama A. S. Anang
grade
Preferred source (of 2)‎

Combination anti–CTLA-4 plus anti–PD-1 checkpoint blockade utilizes cellular mechanisms partially distinct from monotherapies

Proceedings of the National Academy of Sciences
2019-11-05 | Journal article
DOI: 10.1073/pnas.1821218116
Part of ISSN: 0027-8424
Part of ISSN: 1091-6490
Source: Self-asserted source
Nana-Ama A. S. Anang

Negative Co-stimulation Constrains T Cell Differentiation by Imposing Boundaries on Possible Cell States

Immunity
2019-04 | Journal article
DOI: 10.1016/j.immuni.2019.03.004
Part of ISSN: 1074-7613
Source: Self-asserted source
Nana-Ama A. S. Anang

Distinct Cellular Mechanisms Underlie Anti-CTLA-4 and Anti-PD-1 Checkpoint Blockade

Cell
2017 | Journal article
DOI: 10.1016/j.cell.2017.07.024
EID:

2-s2.0-85028060533
Contributors: Wei, S.C.; Levine, J.H.; Cogdill, A.P.; Zhao, Y.; Anang, N.-A.A.S.; Andrews, M.C.; Sharma, P.; Wang, J.; Wargo, J.A.; Pe'er, D. et al.
Source: Self-asserted source
Nana-Ama A. S. Anang via Scopus - Elsevier
How many people are using ORCID?